Abbott India Reports Unaudited Financial Results for Q2 2026

Abbott India has released its unaudited financial results for the quarter and half-year ended September 30, 2025. The company reported a profit before tax of ₹545.93 crores for the quarter and ₹1,039.06 crores for the half-year. Revenue from operations stood at ₹1,757.15 crores for the quarter. The Board of Directors approved these results on November 6, 2025.

Financial Performance Overview

Abbott India announced its unaudited financial results for the second quarter (Q2) and the first half of fiscal year 2026. Key financial highlights include:

  • Revenue from operations: ₹1,757.15 crores for the quarter.
  • Other income: ₹69.95 crores for the quarter.
  • Total Income: ₹1,827.10 crores for the quarter.
  • Profit before tax: ₹545.93 crores for the quarter and ₹1,039.06 crores for the half-year.
  • Profit for the period: ₹415.27 crores for the quarter and ₹781.13 crores for the half-year.

Key Expenses

The company’s expenses for the quarter consisted of:

  • Cost of materials consumed: ₹162.59 crores.
  • Purchases of stock-in-trade: ₹733.32 crores.
  • Employee benefits expense: ₹158.98 crores.
  • Finance costs: ₹7.55 crores.
  • Depreciation and amortisation expense: ₹18.64 crores.
  • Other expenses: ₹159.15 crores.

Balance Sheet Highlights

As of September 30, 2025, key assets and liabilities include:

  • Total Equity: ₹4,010.91 crores.
  • Total Assets: ₹5,694.46 crores.
  • Financial Assets: ₹1,418.13 crores in Non-current assets and ₹507.31 crores in current assets.
  • Inventories: ₹937.86 crores.
  • Cash and cash equivalents: ₹591.10 crores.

Cash Flow Summary (First Half 2026)

Key cash flow metrics for the six months ended September 30, 2025:

  • Net cash from operating activities: ₹521.94 crores.
  • Net cash from investing activities: ₹548.35 crores.
  • Net cash used in financing activities: ₹(1,039.78) crores.

Source: BSE

Previous Article

Procter & Gamble Hygiene and Health Care Unaudited Financial Results for Quarter Ended September 30, 2025

Next Article

Clean Science Board Approves Director Appointments & Financial Results

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *